June 5, 2024

Antibody Production Market Size to Garner USD 66.26 Billion by 2032

The global antibody production market size was estimated to be around US$ 19.4 billion in 2022. It is projected to reach US$ 66.26 billion by 2032, indicating a CAGR of 13.07% from 2023 to 2032.

Antibody Production Market Size 2023 To 2032


Key Takeaways:

  • North America contributed more than 40% of revenue share in 2022.
  • By Poduct, the consumables segment generated with a largest market share of 57% in 2022.
  • By Process, the downstream segment held the highest market share of 68% in 2022.
  • By Type, the monoclonal antibody segment recorded more than 65% of revenue share in 2022.
  • By End-use, the pharmaceutical and biotechnology companies segment captured more than 56% of revenue share in 2022.

The market research report on the Antibody production market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of Antibody production products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.

Get a Sample: https://www.precedenceresearch.com/sample/3212

Report Scope of the Antibody Production Market:

Report Coverage Details
Market Size in 2023 USD 21.94 Billion
Market Size by 2032 USD 66.26 Billion
Growth Rate from 2023 to 2032 CAGR of 13.07%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2022
Forecast Period 2023 To 2032
Segments Covered By Product, By Process, By Type, and By End-use
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Read More: Endocrine Testing Market Size to Reach USD 12.8 Billion by 2032

The report presents the volume and value-based market size for the base year 2022 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.

Focusing on the global Antibody production market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the Antibody production market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.

Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of Antibody production products across different countries and applications.

Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2023 to 2032. It also includes accurate figures for production capacity and production by region during the same period.

The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.

This in-depth research report offers valuable insights into the Antibody production market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.

The competitive landscape section of the report provides detailed information on Antibody production market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the Antibody production market.

Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance. The report

Reasons to Purchase this Report:

  • Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
  • In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
  • Market size in USD million and volume in million units provided for each segment and sub-segment.
  • Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
  • Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.

Key Players

  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • PerkinElmer, Inc.
  • BGI
  • Illumina, Inc.
  • Agilent Technologies
  • Pacific Biosciences of California, Inc.
  • ProPhase Labs, Inc. (Nebula Genomics)
  • Psomagen
  • Azenta US, Inc.

Antibody Production Market Segmentations

By Product

  • Instruments
  • Consumables
  • Software

By Process

  • Upstream Processing
  • Downstream Processing

By Type

  • Monoclonal Antibody
  • Polyclonal Antibody

By End-use

  • Pharmaceutical and Biotechnology Companies
  • Research Laboratories
  • CROs and CDMOs

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Antibody Production Market 

5.1. COVID-19 Landscape: Antibody Production Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Antibody Production Market, By Product

8.1. Antibody Production Market Revenue and Volume Forecast, by Product, 2023-2032

8.1.1. Instruments

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Consumables

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Software

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Antibody Production Market, By Process

9.1. Antibody Production Market Revenue and Volume Forecast, by Process, 2023-2032

9.1.1. Upstream Processing

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Downstream Processing

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Antibody Production Market, By Type 

10.1. Antibody Production Market Revenue and Volume Forecast, by Type, 2023-2032

10.1.1. Monoclonal Antibody

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Polyclonal Antibody

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Antibody Production Market, By End-use 

11.1. Antibody Production Market Revenue and Volume Forecast, by End-use, 2023-2032

11.1.1. Pharmaceutical and Biotechnology Companies

11.1.1.1. Market Revenue and Volume Forecast (2020-2032)

11.1.2. Research Laboratories

11.1.2.1. Market Revenue and Volume Forecast (2020-2032)

11.1.3. CROs and CDMOs

11.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 12. Global Antibody Production Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.1.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.1.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.1.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.1.5.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.1.5.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.1.5.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.1.6.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.1.6.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.1.6.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.2.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.2.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.5.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.2.5.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.2.5.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.6.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.2.6.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.2.6.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.7.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.2.7.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.2.7.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.8.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.2.8.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.2.8.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.3.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.3.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.5.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.3.5.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.3.5.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.6.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.3.6.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.3.6.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.7.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.3.7.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.3.7.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.8.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.3.8.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.3.8.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.4.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.4.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.5.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.4.5.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.4.5.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.6.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.4.6.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.4.6.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.7.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.4.7.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.4.7.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.8.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.4.8.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.4.8.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.5.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.5.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.5.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.5.5.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.5.5.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.5.5.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.5.6.2. Market Revenue and Volume Forecast, by Process (2020-2032)

12.5.6.3. Market Revenue and Volume Forecast, by Type (2020-2032)

12.5.6.4. Market Revenue and Volume Forecast, by End-use (2020-2032)

Chapter 13. Company Profiles

13.1. QIAGEN

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Thermo Fisher Scientific, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. PerkinElmer, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. BGI

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Illumina, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Agilent Technologies

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Pacific Biosciences of California, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. ProPhase Labs, Inc. (Nebula Genomics)

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Psomagen

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Azenta US, Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *